Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

881 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The IGF-1R pathway as a therapeutic target.
Chu E. Chu E. Oncology (Williston Park). 2011 May;25(6):538-9, 543. Oncology (Williston Park). 2011. PMID: 21717909 No abstract available.
Phase I study of veliparib in combination with gemcitabine.
Stoller R, Schmitz JC, Ding F, Puhalla S, Belani CP, Appleman L, Lin Y, Jiang Y, Almokadem S, Petro D, Holleran J, Kiesel BF, Ken Czambel R, Carneiro BA, Kontopodis E, Hershberger PA, Rachid M, Chen A, Chu E, Beumer JH. Stoller R, et al. Among authors: chu e. Cancer Chemother Pharmacol. 2017 Sep;80(3):631-643. doi: 10.1007/s00280-017-3409-3. Epub 2017 Aug 2. Cancer Chemother Pharmacol. 2017. PMID: 28770300 Free PMC article. Clinical Trial.
Can metastatic colorectal cancer be cured?
Bartlett DL, Chu E. Bartlett DL, et al. Among authors: chu e. Oncology (Williston Park). 2012 Mar;26(3):266-75. Oncology (Williston Park). 2012. PMID: 22545311 Review.
881 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page